Rocuronium Bromide Injection, Solution
Product Images NDC 65145-130

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 65145-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rcb-spl-100mg-10ml-carton (Rcb Spl 100mg 10ml Carton)

Carton label for Rocuronium Bromide Injection 10 mg/mL (100 mg/10 mL) by Caplin Steriles Limited. The label includes dosage strength, paralyzing agent warning, and directions for intravenous use only. It specifies packaging of 10 vials of 10 mL multiple-dose solution. Storage and manufacturing details are noted, along with a barcode and NDC 65145-131-10.*

FDA Label Image

Rcb-spl-100mg-10ml-label (Rcb Spl 100mg 10ml Label)

Rocuronium Bromide Injection label showing strength 100 mg/10 mL (10 mg/mL) in a multiple-dose vial. The label indicates it is for intravenous use only and includes warnings that it is a paralyzing agent causing respiratory arrest, requiring facilities to be immediately available for artificial respiration. Storage instructions specify refrigeration between 2° to 8°C and to avoid freezing. Manufacturer is Caplin Steriles Limited, India.*

FDA Label Image

Rcb-spl-50mg-5ml-carton (Rcb Spl 50mg 5ml Carton)

Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) vial carton label showing product name, concentration, and warning that it is a paralyzing agent. The label states it is for intravenous use only and that the package contains ten 5 mL multiple-dose vials. Manufactured by Caplin Steriles Limited, India. The label includes storage instructions and a barcode.*

FDA Label Image

Rcb-spl-50mg-5ml-label (Rcb Spl 50mg 5ml Label)

Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) vial label for intravenous use. The label states it is a sterile, nonpyrogenic, multiple-dose vial containing 5 mL of solution. It includes a red warning about the drug being a paralyzing agent causing respiratory arrest, with storage instructions and manufacturer information for Caplin Steriles Limited, India.*

FDA Label Image

Rcb-spl-structure (Rcb Spl Structure)

Chemical structure of rocuronium bromide depicted as a detailed molecular diagram, showing the arrangement of multiple rings, functional groups, and the bromide ion (Br). This structure represents the active ingredient in rocuronium bromide injection, solution for intravenous use.*

FDA Label Image

Rcb-spl-structure02 (Rcb Spl Structure02)

Box plot chart depicting the distribution of an unspecified variable measured in minutes across different age groups (18-64 years, 65 years and older, and 1-12 years) and dose levels in mg/kg. The x-axis shows dose range by age group, and the y-axis represents time in minutes with scattered data points and variability indicated by boxes and whiskers.*

FDA Label Image

Rcb-spl-structure03 (Rcb Spl Structure03)

A box plot chart comparing values measured in minutes across four age and dosage groups: 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years. Each group shows multiple data points represented with outliers, illustrating variations in duration or effect for varying doses in mg/kg.*

FDA Label Image

Rcb-spl-structure04 (Rcb Spl Structure04)

A line graph showing the relationship between dose number (1 to 6) and time in minutes (0 to 30) for two dosage levels, 0.1 mg/kg and 0.15 mg/kg. The graph includes data points with lines, comparing time across different dose numbers for each dose, with sample sizes indicated as N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.